In developed countries, resistance testing has been adopted as the standard of care for the treatment of HIV-1 infection. The clinical utility of resistance testing for therapeutic decision-making in patients who have failed antiretroviral drug therapy is no longer controversial. Instead, drug resistance testing has become an essential tool to assist clinicians in the selection of potent antiretroviral drug regimens that will enhance the likehood of favourable treatment responses.
Copyright © 2006, Mediscript.